Our Speakers and Panelists
Agus Rodriguez-Granillo
Senior Principal Scientist
Schrödinger
Alberto Valero de la Cruz
Medicinal Chemist
Eli Lilly
Alexander Hillisch
Head of Global CADD
UCB
Ana Negri
Director, Therapeutics Group
Schrödinger
Anders Hogner
Senior Director, Medicinal Chemistry
AstraZeneca
Bryce Harrison
Senior Director, Chemistry
Morphic Therapeutic
Daniele Pala
Senior Principal Scientist, Computational Chemistry
Chiesi Farmaceutici
Eric Therrien
Director, Therapeutics Group
Schrödinger
Jean-Philippe Rameau
Head of Molecular Design Sciences
Sanofi
Lena Tagmose
Director of Global External Innovation & Drug Discovery
Angelini Pharma
Leonardo De Maria
Principal Scientist
AstraZeneca
Luc van Hijfte
President, Senior VP Drug Discovery
EFMC, Symeres
Marco Montefiori
Principal Scientist, Protein Engineering
Ichnos Sciences
Miriam López-Ramos
Group Leader Computational Drug Design
Galapagos
Paraskevi Gkeka
Principal Scientist
Sanofi
Mrs. Preeyantee Ghosh
Technology Product Owner, Synthetic Molecular Design
Johnson & Johnson Innovative Medicine
Richard A. Friesner
Professor of Chemistry
Columbia University
Robert Abel
Executive Vice President, Chief Scientific Officer, Platform
Schrödinger
Soufyan Jerhaoui
Senior Scientist, Team Leader
Johnson & Johnson Innovative Medicine
Xiaoguang Xue
Senior Scientist
Genmab
Yann Foricher
Head of Small Molecules Medicinal Chemistry
Sanofi
Zhe Nie
Executive Director, Therapeutics Group
Schrödinger
